Health Equity Venture Firm Syridex Bio to Invest $5 Million to Reduce NJ Health Disparities
Syridex Bio, a life sciences impact investment firm, announced today that it has been chosen by the New Jersey Economic Development Authority (NJEDA) to manage and invest up to $5 […]
